UG Healthcare says Omicron still in its early days, company to monitor situation
GLOVEMAKERS are now back in the spotlight, thanks to the Omicron coronavirus variant, which has sparked hopes of renewed demand and stronger average selling prices (ASPs) for gloves.
Lee Jun Yih, executive director of UG Healthcare, is not prepared to speculate about the impact the new variant will have on the company’s business though, saying that it is “still early days”.
In a recent interview with The Business Times, he said UG Healthcare is still monitoring the situation, and is unable to say for sure what the impact of the Omicron variant will be on demand, ASPs and profits.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
SocGen Q1 profit slumps less than expected as investment bank surprises
Wall Street Journal moves Asia headquarters from Hong Kong to Singapore
Macquarie sees biggest profit dip in 15 years on commodities downturn
HSBC appoints ex-Citi banker as new Singapore head of global banking
H2G Green chief to stand trial on Aug 5 amid MOM probe
Dasin Retail Trust’s trustee-manager chairman, directors deny allegations of misconduct